Navamedic ASA (NAVA) - Total Assets

Latest as of December 2025: Nkr741.75 Million NOK ≈ $78.05 Million USD

Based on the latest financial reports, Navamedic ASA (NAVA) holds total assets worth Nkr741.75 Million NOK (≈ $78.05 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See NAVA book value for net asset value and shareholders' equity analysis.

Navamedic ASA - Total Assets Trend (2003–2025)

This chart illustrates how Navamedic ASA's total assets have evolved over time, based on quarterly financial data.

Navamedic ASA - Asset Composition Analysis

Current Asset Composition (December 2025)

Navamedic ASA's total assets of Nkr741.75 Million consist of 36.7% current assets and 63.4% non-current assets.

Asset Category Amount (NOK) % of Total Assets
Cash & Equivalents Nkr74.16 Million 9.8%
Accounts Receivable Nkr43.30 Million 5.8%
Inventory Nkr116.56 Million 15.7%
Property, Plant & Equipment Nkr6.19 Million 0.8%
Intangible Assets Nkr250.89 Million 33.8%
Goodwill Nkr207.57 Million 28.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Navamedic ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Navamedic ASA market capitalisation.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Navamedic ASA's current assets represent 36.7% of total assets in 2025, a decrease from 51.8% in 2003.
  • Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 335.6% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 30.0% in 2003.
  • Asset Diversification: The largest asset category is intangible assets at 33.8% of total assets.

Navamedic ASA Competitors by Total Assets

Key competitors of Navamedic ASA based on total assets are shown below.

Company Country Total Assets
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$7.84 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Cyclopharm Ltd
AU:CYC
Australia AU$55.91 Million
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
China CN¥233.15 Billion
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
China CN¥83.17 Billion

Navamedic ASA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.55 1.42 1.11
Quick Ratio 0.89 0.84 0.68
Cash Ratio 0.42 0.26 0.00
Working Capital Nkr96.77 Million Nkr59.18 Million Nkr12.13 Million

Navamedic ASA - Advanced Valuation Insights

This section examines the relationship between Navamedic ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.46
Latest Market Cap to Assets Ratio 0.06
Asset Growth Rate (YoY) 51.0%
Total Assets Nkr741.75 Million
Market Capitalization $47.82 Million USD

Valuation Analysis

Below Book Valuation: The market values Navamedic ASA's assets below their book value (0.06x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Navamedic ASA's assets grew by 51.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Navamedic ASA (2003–2025)

The table below shows the annual total assets of Navamedic ASA from 2003 to 2025.

Year Total Assets Change
2025-12-31 Nkr741.75 Million
≈ $78.05 Million
+50.99%
2024-12-31 Nkr491.24 Million
≈ $51.69 Million
-6.31%
2023-12-31 Nkr524.30 Million
≈ $55.17 Million
+36.98%
2022-12-31 Nkr382.77 Million
≈ $40.28 Million
+15.93%
2021-12-31 Nkr330.18 Million
≈ $34.74 Million
+26.97%
2020-12-31 Nkr260.04 Million
≈ $27.36 Million
+39.02%
2019-12-31 Nkr187.06 Million
≈ $19.68 Million
-12.89%
2018-12-31 Nkr214.73 Million
≈ $22.60 Million
-13.16%
2017-12-31 Nkr247.27 Million
≈ $26.02 Million
-14.04%
2016-12-31 Nkr287.67 Million
≈ $30.27 Million
+4.40%
2015-12-31 Nkr275.55 Million
≈ $29.00 Million
+29.24%
2014-12-31 Nkr213.20 Million
≈ $22.44 Million
+18.79%
2013-12-31 Nkr179.48 Million
≈ $18.89 Million
+34.19%
2012-12-31 Nkr133.75 Million
≈ $14.07 Million
-3.83%
2011-12-31 Nkr139.07 Million
≈ $14.63 Million
+12.77%
2010-12-31 Nkr123.33 Million
≈ $12.98 Million
-9.69%
2009-12-31 Nkr136.55 Million
≈ $14.37 Million
-14.47%
2008-12-31 Nkr159.65 Million
≈ $16.80 Million
-13.92%
2007-12-31 Nkr185.46 Million
≈ $19.52 Million
+253.76%
2006-12-31 Nkr52.42 Million
≈ $5.52 Million
+9.23%
2005-12-31 Nkr47.99 Million
≈ $5.05 Million
+180.89%
2004-12-31 Nkr17.09 Million
≈ $1.80 Million
+2116.74%
2003-12-31 Nkr770.79K
≈ $81.11K
--

About Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$47.82 Million
Nkr454.45 Million NOK
Market Cap Rank
#22062 Global
#204 in Norway
Share Price
Nkr18.95
Change (1 day)
-0.26%
52-Week Range
Nkr18.95 - Nkr26.40
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more